WITHDRAWN: Drugs for preventing postoperative nausea and vomiting.

@article{Carlisle2017WITHDRAWNDF,
  title={WITHDRAWN: Drugs for preventing postoperative nausea and vomiting.},
  author={J. Carlisle and C. A. Stevenson},
  journal={The Cochrane database of systematic reviews},
  year={2017},
  volume={7},
  pages={
          CD004125
        }
}
BACKGROUND Drugs can prevent postoperative nausea and vomiting, but their relative efficacies and side effects have not been compared within one systematic review. OBJECTIVES The objective of this review was to assess the prevention of postoperative nausea and vomiting by drugs and the development of any side effects. SEARCH METHODS We searched The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, Issue 2, 2004), MEDLINE (January 1966 to May 2004), EMBASE… Expand
Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.
TLDR
Evidence of the efficacy and safety of antiemetic medications in the management of nausea and vomiting in the adult ED setting is provided to provide evidence of the superiority andSafety of any particular drug compared to active control. Expand
Haloperidol for the treatment of nausea and vomiting in palliative care patients.
TLDR
There is incomplete evidence from published RCTs to determine the effectiveness of haloperidol for nausea and vomiting in palliative care, and two trials are underway. Expand
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
BACKGROUND Postoperative nausea and vomiting (PONV) is a common adverse effect of anaesthesia and surgery. Up to 80% of patients may be affected. These outcomes are a major cause of patientExpand
Adverse side effects of dexamethasone in surgical patients
TLDR
A single dose of dexamethasone probably does not increase the risk for postoperative infection and may produce a mild increase in glucose levels among participants without diabetes during the first 12 hours after surgery, which suggests a mild effect on delayed wound healing in the general surgical population. Expand
Original Article Efficacy of dexmedetomidine on postoperative nausea and vomiting: a meta-analysis of randomized controlled trials
TLDR
It is indicated that dexmedetomidine shows superiority to placebo, but not to all other anesthetic agents on PONV, and this efficacy may be related to a reduced consumption of intraoperative opioids. Expand
Supplemental perioperative intravenous crystalloids for postoperative nausea and vomiting.
TLDR
There is moderate-certainty evidence that supplemental perioperative intravenous crystalloid administration reduces PON and POV, in ASA class I to II patients receiving general anaesthesia for ambulatory or short length of stay surgical procedures. Expand
Amisulpride Prevents Postoperative Nausea and Vomiting in Patients at High Risk: A Randomized, Double-blind, Placebo-controlled Trial
TLDR
Intravenous amisulpride was safe and effective as prophylaxis of postoperative nausea and vomiting when given in combination with an antiemetic from another class to adult patients at high risk for suffering postoperative sickness and vomiting undergoing elective surgery under inhalational general anesthesia. Expand
Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting.
TLDR
Heterogeneity among trials was substantial and there were study limitations, but the quality of evidence was moderate, due to the study limitations. Expand
Intravenous versus inhalational anesthesia for pediatric inpatient surgery - A systematic review and meta-analysis.
TLDR
Taken together, propofol increased the risk of oculocardiac reflex whereas PONV was less frequent following intravenous anesthetics compared to volatile anESThetics, which may help tailoring the use of either intravenous of volatile anesthetic agents onto the needs of pediatric inpatients. Expand
Nausea and Vomiting
TLDR
Monitoring of patients with nausea and/or vomiting is important to ensure optimal symptom management, prevention or correction of dehydration, and resolution of the underlying cause. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 783 REFERENCES
Efficacy and adverse effects of prophylactic antiemetics during patient-controlled analgesia therapy: a quantitative systematic review.
TLDR
A systematic search for randomized trials published up to May 1998 compared prophylactic antiemetic interventions with placebo or no treatment in the postoperative PCA-setting with opioids found no evidence of dose-responsiveness for efficacy with droperidol, but the risk of adverse effects is dose-dependent. Expand
Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting
TLDR
Droperidol is anti-emetic in the surgical setting, Sedation and drowsiness are dose-dependent, extrapyramidal symptoms are rare, and there is a protective effect against headache. Expand
Efficacy, Dose‐Response, and Safety of Ondansetron in Prevention of Postoperative Nausea and Vomiting: A Quantitative Systematic Review of Randomized Placebo‐controlled Trials
TLDR
If the risk of PONV is very high, for every 100 patients receiving an adequate dose of ondansetron 20 patients will not vomit and three will have a headache who would not have had these adverse effects without the drug. Expand
Evaluation of the effective drugs for the prevention of nausea and vomiting induced by morphine used for postoperative pain: a quantitative systematic review.
TLDR
Of them, dexamethasone used as a prophylactic drug for PONV provided the best results, and is suggested to be suitable as a first drug of choice. Expand
Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies.
TLDR
There was no evidence of dose-responsiveness with oral, i.m., intranasal or i.v. metoclopramide in children and adults, and there was one adult who experienced extrapyramidal symptoms with metoclobramide. Expand
Ondansetron in the prophylaxis of postoperative vomiting: a meta-analysis.
TLDR
While ondansetron is an effective antiemetic with minimal adverse effects, the data obtained on the numbers needed to be treated calculation for prophylaxis of postoperative vomiting should be considered in future cost-effective strategies of postoperatively management. Expand
Dolasetron for the prevention of postoperative nausea and vomiting following outpatient surgery with general anaesthesia: a randomized, placebo-controlled study. The Dolasetron PONV Prevention Study Group.
TLDR
Dolasetron provided well-tolerated, safe, and effective prophylaxis for post-operative nausea and vomiting with maximum effectiveness observed at a dose of 12.5 mg, with no additional benefit in complete response rates or nausea visual analogue scale scores at higher doses. Expand
Comparison of ondansetron and placebo for preventing postoperative nausea and emesis in gastrointestinal tract surgery: a multicenter randomized controlled trial.
TLDR
Ondansetron 4 mg given intravenously before surgery is safe and effective for preventing postoperative nausea and emesis following gastrointestinal tract surgery. Expand
A Double‐Blind, Placebo‐Controlled Evaluation of Intranasal Metoclopramide in the Prevention of Postoperative Nausea and Vomiting
TLDR
The results showed that this intranasal dose of metoclopramide may be ineffective in preventing the occurrence of PONV and may be due to an inadequate dose or slow absorption of the drug. Expand
Prophylactic oral antiemetics for preventing postoperative nausea and vomiting : Granisetron versus domperidone
TLDR
In conclusion, the efficacy of preoperative oral granisetron is superior to that of domperidone for the prevention of PONV after major gynecologic surgery. Expand
...
1
2
3
4
5
...